Ruti Aga and the Six-Year Arithmetic: Two Years for the Injection, Four for a Prescription That Never Existed

September 10 turns up twice in this case. Once when Ruti Aga was provisionally suspended, and once when her six-year ban formally began. Both counted from the same day. On paper that reads like relief. In practice it is arithmetic — the months spent under investigation were simply subtracted from the sentence, nothing more.

There were three sheets of paper on the table on my rooftop that evening. The first was the Athletics Integrity Unit's statement, released on Thursday. The second was the line inside it that named the drug — methylprednisolone. The third was a newspaper cutting describing that same drug as a "prohibited steroid" and asserting that Wada classes it as performance enhancing.

The third sheet was wrong.

Methylprednisolone is not an anabolic steroid. It is a glucocorticoid, class S9 on the Wada Prohibited List, and the critical condition on S9 is that it is prohibited in-competition only — by injection, oral or rectal route. A knee injection given out of competition is a lawful medical treatment. It becomes a violation the moment residues are present in a sample taken in-competition.

That single sentence re-routes the entire case. It is also where I begin.

I kept my first ledger by hand in Pune in 2026, and the habit has not changed since — numbers first, narrative second. When a player came on tape, the question was never what kind of man he was. The question was what the lines said. Same discipline applies here.

Context: two numbers the statement gives, and one drug class the reporting got wrong

Ruti Aga is a 32-year-old Ethiopian marathoner. According to the AIU statement, she won a half marathon in China in March, and the sample taken afterwards returned methylprednisolone. Her explanation cited a knee injury. The prescription submitted in support named a clinic that does not exist, was attributed to a "doctor" who is a family member with no medical registration, and was defended on the grounds that an old prescription pad from a former workplace had been used — a defence the clinic in question explicitly disowned.

The sanction arithmetic came out as two years for the presence violation and four years for tampering, six in total.

The correction matters more than the sanction, and I file it at the top because every downstream comparison depends on it. Methylprednisolone is not a strength-building anabolic agent. It is a glucocorticoid under class S9, and the prohibition bites in-competition. Printing "steroid" files this case alongside bench-press and sprint cases where it does not belong. Where this drug actually sits in marathon medicine is a different question entirely.

The sampling note, as always on any data-led piece. There is no performance number in this file. No time for the Chinese half marathon, no splits, no field strength, no weather. We know only that she won it. So I will not describe her form. What the ledger does not hold, I do not print. That rule set hard on the Russia World Cup desk, which ran on chai, spreadsheets, and a stubborn refusal to guess.

What the ledger does hold: the 2026 Tokyo Marathon title and three second-place finishes at World Marathon Majors. From external recall, her personal best sits in the 2:18–2:20 class — second in Berlin 2026, first in Tokyo 2026. Those numbers are not in the statement and I flag them as pending verification. They do establish the tier, though. This was a genuinely elite marathoner, peaking in 2026 and 2026.

Without that context the case reads as routine. It is not routine. A six-year ban has landed on a Major winner.

Core: four years for the paper, two for the needle

Break the sanction apart. Two years for the presence violation — the prohibited substance found in the sample. Four years for tampering — false information given in the investigation, supported by a fabricated document. Six in total.

That arithmetic is itself a finding. Under the Code, presence carries a four-year baseline that drops to two where intent is not established or where the substance is specified. She received two — the panel placed the drug offence at the lenient end. The bulk of the six is not the drug. It is the paperwork.

Anyone reading this as "six years for a medication" has skipped a line in the ledger.

Now the question the cutting never asked. If the knee injury was real, if an injection genuinely happened, a defence existed. A glucocorticoid injection administered out of competition is legal. The only condition is that no residue remains on race day — correct route, correct timing, correct documentation. A road race's testing window opens at 23:59 the day before the race, which means an injection given days earlier can be caught. This is not obscure knowledge. It is a team physician's daily arithmetic.

There was no team physician.

Three verification failures are recorded, and each is fatal in a different register. First, the clinic named on the prescription did not exist. Second, the person described as a doctor was an unregistered family member. Third, the "old prescription pad" explanation was rejected outright by the clinic whose pad it supposedly was.

Any one of those might have been survived. Three together remove the possibility of coincidence. One forged document is an event. A falsehood operating at three independent levels, joined by a single intent, closes the space a defence needs.

Every transfer leaves a paper trail; I read the paper before the shouting starts. Here the paper is the case.

And the most neglected part of the file — the knee

The root of this episode is an injury. Chronic knee pathology is not an exception among marathoners; it is the sport's routine overhead. In a body running 180–200 kilometres a week, the knee speaks first. And when it speaks, a glucocorticoid injection is the cheapest, most available, fastest answer.

This is where individual carelessness separates from collective architecture. A 32-year-old who has won a Major draws much of her income from appearance fees and race purses, which creates a financial incentive to mask pain. The Chinese label-race circuit performs exactly that function for East African marathoners — a lucrative, low-risk income tier between Majors. That same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding inside the same races.

That collision is not a question about one athlete's ethics. It is a question about a system's medical governance, or its absence.

One detail deserves flagging because it will shape future cases. The four-year tampering sanction did not arise from a document alone. Per the AIU statement it also rests on statements made during the investigation — meaning the conditions of the interview are part of the penalty. Language and translation in AIU interviews with East African athletes has been a recurring point of contention. I cannot prove it operated here, so I will not claim it. But it is an open column in the ledger, and I do not close open columns.

What survives — and that matters

The violation is anchored to that March race. Absent a finding of earlier use, results before that date are not automatically annulled. The 2026 Tokyo title and the three Major second places remain on the record, unless the statement has defined the disqualification scope otherwise. The statement does not define it. I will not assume it. I will only log it.

What can be assumed with reasonable confidence is the voiding of that March race — result, ranking points, prize money. Standard AIU practice disqualifies the competition where the sample was collected. The line is absent from the statement; the procedure is not.

Now the career arithmetic. Six years from September 10. At 32, she returns at roughly 38. Given the depth of Ethiopian women's marathon running, a 38-year-old with a doping record is effectively unselectable. In the language of the sport this is six years. In the language of a career it is an ending.

Contrarian: this case is not about a drug, it is about a document

The first reading forming in public is that the AIU has shown severity by handing six years for a glucocorticoid. That reading has a flaw. No severity was shown on the drug — that portion drew two years, the soft end of its range. The severity landed on a prescription that was never written in any clinic.

That distinction matters, because it moves the case out of the "crackdown on African road runners" frame and into the "document verification" frame. You can argue about the dose. There is very little to argue about in a forged prescription.

The second reading forms instantly — she won a half marathon in China, so her form was good. This is where I stop. Winning is a result. A time is evidence. There is no time. There is no form. That conclusion comes from the gut, not the ledger, and I will not print it.

The third reading is the uncomfortable one. The easy way to read this case is that an athlete was careless and got caught. The harder way is that an injured 32-year-old had no credentialed medical structure around her, took the first route available, and that route ran through a family member holding an old prescription pad.

Both things can be true at once. The athlete is responsible, and so is the structure. Six years answers the first. No sanction answers the second.

And this is the trap I fall into myself — the reflex to hunt the counter-intuitive read. Not every case hides an angle. Sometimes the boring number is the true number: two years for the drug, four for the lie, six in total. That is all. Here the boring number is true.

One professional note. The AIU statement was released on Thursday. What the statement says is the strongest available ground. What a clinic commentator says is a different order of evidence. Decades in this trade taught me to keep two lists — what administrators say, and what then happens. That list is open here: the disqualification scope is unstated, the age appears in one place only, the year of the March race is not given. Filling blanks is not my job.

Takeaway: the next story is not the one you are expecting

The durable lesson of this case is not in its length. It is in its shape. The enforcement frontier in road running has moved from detection to verification. Finding a substance is one thing; auditing the paperwork submitted afterwards is another. The AIU's real stake now sits at the second desk.

Which is why the next story will not be what people assume. The interesting question is not which runner is caught next. The interesting question is whether a charge ever reaches an agent, a manager or a camp's medical support. This statement names the one family member who produced the prescription. Who advised him is not in it.

The day a clear TUE record exists inside an East African training camp's medical structure, cases of this type will halve. Sanctions do not change architecture. Architecture changes sanctions.

I am a monk of small numbers, and the rooftop is my chapel. On this file I hold two figures I trust completely — two and four. And one figure I do not hold — the time from that March half marathon. The day it arrives, I will write another paragraph on this case. The day it does not, the column stays open. That is how a ledger stays honest.